Literature DB >> 22202844

Molecular pharmacology of the mouse melatonin receptors MT₁ and MT₂.

Séverine Devavry1, Céline Legros, Chantal Brasseur, William Cohen, Sophie-Pénélope Guenin, Philippe Delagrange, Benoît Malpaux, Christine Ouvry, Francis Cogé, Olivier Nosjean, Jean A Boutin.   

Abstract

The main melatonin receptors are two G-protein coupled receptors named MT(1) and MT(2). Having described the molecular pharmacology of the human versions of these receptors, we turned to two of the three species most useful in studying melatonin physiology: rat and sheep (a diurnal species used to understand the relationship between circadian rhythm and depression). We also employed previously used compounds to describe the mouse melatonin receptors; despite the early cloning of mouse receptors, few molecular pharmacology studies on these receptors exist. To our surprise, we detected no major differences between the data obtained from mice and those from other species.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22202844     DOI: 10.1016/j.ejphar.2011.12.009

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  12 in total

1.  Melatonin MT₁ and MT₂ receptors display different molecular pharmacologies only in the G-protein coupled state.

Authors:  Céline Legros; Séverine Devavry; Sarah Caignard; Clémence Tessier; Philippe Delagrange; Christine Ouvry; Jean A Boutin; Olivier Nosjean
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

Review 2.  Understanding melatonin receptor pharmacology: latest insights from mouse models, and their relevance to human disease.

Authors:  Gianluca Tosini; Sharon Owino; Jean-Luc Guillaume; Ralf Jockers
Journal:  Bioessays       Date:  2014-06-05       Impact factor: 4.345

3.  MT1 Receptor Signaling Pathways by Impedance Measurement.

Authors:  Anne Bonnaud; Clémence Dupré; Céline Legros; Jean A Boutin
Journal:  Methods Mol Biol       Date:  2022

4.  Why Are We Still Cloning Melatonin Receptors? A Commentary.

Authors:  Célia Gautier; Isabelle Theret; Giulia Lizzo; Gilles Ferry; Sophie-Pénélope Guénin; Jean A Boutin
Journal:  Methods Mol Biol       Date:  2022

Review 5.  Circadian clocks of the kidney: function, mechanism, and regulation.

Authors:  Hannah M Costello; Jermaine G Johnston; Alexandria Juffre; G Ryan Crislip; Michelle L Gumz
Journal:  Physiol Rev       Date:  2022-05-16       Impact factor: 46.500

Review 6.  Melatonin: a potential intervention for hepatic steatosis.

Authors:  Hang Sun; Fang-fang Huang; Shen Qu
Journal:  Lipids Health Dis       Date:  2015-07-22       Impact factor: 3.876

7.  Recombinant human melatonin receptor MT1 isolated in mixed detergents shows pharmacology similar to that in mammalian cell membranes.

Authors:  Christel Logez; Sylvie Berger; Céline Legros; Jean-Louis Banères; William Cohen; Philippe Delagrange; Olivier Nosjean; Jean A Boutin; Gilles Ferry; Frédéric Simonin; Renaud Wagner
Journal:  PLoS One       Date:  2014-06-24       Impact factor: 3.240

8.  Characterization of the Mel1c melatoninergic receptor in platypus (Ornithorhynchus anatinus).

Authors:  Célia Gautier; Sophie-Penelope Guenin; Isabelle Riest-Fery; Tahlia Jade Perry; Céline Legros; Olivier Nosjean; Valerie Simonneaux; Frank Grützner; Jean A Boutin
Journal:  PLoS One       Date:  2018-03-12       Impact factor: 3.240

9.  New radioligands for describing the molecular pharmacology of MT1 and MT2 melatonin receptors.

Authors:  Céline Legros; Ulrich Matthey; Teresa Grelak; Sandrine Pedragona-Moreau; Werner Hassler; Saïd Yous; Emmanuel Thomas; Franck Suzenet; Benoît Folleas; François Lefoulon; Pascal Berthelot; Daniel-Henri Caignard; Gérald Guillaumet; Philippe Delagrange; Jean-Louis Brayer; Olivier Nosjean; Jean A Boutin
Journal:  Int J Mol Sci       Date:  2013-04-25       Impact factor: 5.923

Review 10.  Melatonin and pancreatic islets: interrelationships between melatonin, insulin and glucagon.

Authors:  Elmar Peschke; Ina Bähr; Eckhard Mühlbauer
Journal:  Int J Mol Sci       Date:  2013-03-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.